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Abstract The breadth of material found in surgical pathol-
ogy services in African countries differs from the common
spectrum of “the West”. We report our experience of a
voluntary work in the pathology departments of Blantyre
and Lilongwe, Malawi. During a 6-week period, 405 cases
(378 histology and 27 cytology cases) were processed. The
vast majority showed significant pathological findings (n0
369; 91.1 %): 175 cases (47.4 %) were non-tumoral con-
ditions with predominance of inflammatory lesions, e.g.,
schistosomiasis (n011) and tuberculosis (n011). There were
39 (10.6 %) benign tumors or tumor-like lesions. Intraepi-
thelial neoplasia of the cervix uteri dominated among pre-
malignant conditions (n015; 4.1 %). The large group of
malignancies (n0140; 37.9 %) comprised 11 pediatric
tumors (e.g., rhabdomyosarcoma, small blue round cell
tumors) and 129 adult tumors. Among women (n076),
squamous cell carcinomas (SCCs) of the cervix uteri pre-
dominated (n025; 32.9 %), followed by breast carcinomas
(n012; 15.8 %) and esophageal SCC (n09; 11.8 %). Males
(n053) most often showed SCC of the esophagus (n09;
17.0 %) and of the urinary bladder (n07; 13.2 %). Lympho-
mas (n07) and Kaposi's sarcomas (n06) were less frequent.
Differences compared to the western world include the
character of the conditions in general, the spectrum of in-
flammatory lesions, and the young age of adult tumor
patients (median 45 years; range 18–87 years). Providing
pathology service in a low-resource country may be handi-
capped by lack of personnel, inadequate material resources,
or insufficient infrastructure. Rotating volunteers offer a
bridge for capacity building of both personnel and the local
medical service; in addition, the volunteer's horizons are
broadened professionally and personally.
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Introduction
Providing pathology service in low-resource countries is
challenging due to the lack of trained personal and technical
equipment and inefficient infrastructure (e.g., transportation,
communication, etc.) [1–3]. The latter of these can be built
quickly when money, demand, and motivation are available;
the former (i.e., personnel) requires time for training which
creates gaps. The challenge of providing high-quality path-
ological services in Africa is limited by the number of
available well-trained and skilled pathologists in a particular
country or medical unit. When indigenous highly skilled
pathologists are available, they may often be so few in
number that the overwhelming challenges of providing
medical education, pathology service, and government/
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administrative responsibilities hinder their day to day sign-
out ability. When a low-resource pathology unit has the
opportunity to add staff to their system, they are still faced
with the gap between the arrivals of the new team members.
One system to overcome this problem which can serve as a
temporary bridge while building the required capacity with
indigenous pathologists is a rotating volunteer system. This
provides qualified pathologist who can insure continuity,
establish turn-around-time goals, and train local medical
staff in the best methods for tissue collection for both
histology and cytology.
Malawi is a small country in southeast Africa bordered
by Tanzania in the north and northeast, Zambia in the west,
and Mozambique in the southeast and southwest. It is one of
the smallest but most densely populated counties in sube-
quatorial Africa with a population of currently around 16
million inhabitants, of whom the vast majority lives in rural
areas. Malawi belongs to the poorest countries in the world
with around 40 % of Malawians living below the interna-
tional poverty line. The economy is essentially agricultural,
and tobacco accounts for 70 % of Malawi's export earnings,
followed by tea and sugar—all mainly grown by smallhold-
er farmers. The country is heavily dependent on foreign aid,
which represents half of its gross domestic product [4].
Like most sub-Saharan countries, Malawi suffers from a
high burden of HIV, with an estimated prevalence of 15 %
for the age group between 15 and 49 years. Tuberculosis and
malaria are common [5, 6]. Major efforts to establish and
improve Malawi's health care system are in process, e.g.,
offering the main health services free of charge. Life expec-
tancy has successfully improved from less than 40 years in
2000 to 52.2 years in 2009 [4].
In Malawi, there are currently two functioning
government-run pathology laboratories situated in the Uni-
versity of Malawi College of Medicine in Blantyre (serving
the majority of the country's hospitals) and at the Kamuzu
Central Hospital in Lilongwe (Malawi's capital). There are
four fully certified pathologists. One of them does forensic
postmortems only and one retired pathologist is providing
service for the Lilongwe lab. The remaining two (TT and
KS) are working at the College of Medicine. Being faculty
members, they are also heavily involved in administrative
and academic duties. Two local residents are currently
abroad and two more are beginning their residency in
2012. All residents are trained in South Africa over a 4-
year period, as special education for pathology residents is
currently not available in Malawi.
In July 2011, a structured support project for the pathol-
ogy service of Malawi was initiated by Danny Milner from
the Department of Pathology, Brigham and Women's Hos-
pital, Boston, USA, in association with the Partners in
Health [7]. The aim of the Pathologists for Malawi Project
(which uses the well-established model provided by the
long-time operating organization “Pathologists Overseas”)
is to provide continuous on-site support by volunteer path-
ologists until local pathology residents finish their training
abroad, thereby shortening turnover times, avoiding larger
backloads, but also creating an intellectual and cultural
exchange between local and foreign pathologists. Here, we
report our individual experience of a 6-week voluntary work
in the pathology departments of Blantyre and Lilongwe,
Malawi, between November and December 2011.
Materials and methods
Pathology laboratories in Blantyre and Lilongwe
The Department of Histopathology in Blantyre is part of the
College of Medicine of Malawi and provides diagnostic
service for the large Queen Elisabeth Central Hospital in
Blantyre and for at least 20 additional hospitals of Blantyre
and the rest of the country. The annual workload reaches
around 3,000 cases for histological examination (estimated
to be approximately 10 % of the actual potential caseload for
the country). Moreover, the department provides pathology
service for a large number of scientific projects, mostly
coordinated from abroad.
In Lilongwe, the histopathologic laboratory is located
within the area of the Kamuzu Central Hospital (KCH),
the capital's largest clinic. The lab is set up and financed
by the University of North Carolina (UNC), which is run-
ning a large research center on the campus. Before the
UNC-sponsored lab was constructed, there were approxi-
mately 150 cases per year from KCH. In the first 6 months
of operation, 700 diagnostic cases processed, creating a
projected caseload of ~1,500 cases annually (a tenfold in-
crease). Because there is no on-site permanent pathologist in
Lilongwe, the slides are produced at KCH but then have to
be sent to Blantyre for reading and signing-out by Professor
George Liomba, the retired former head of the Blantyre
Department of Histopathology. Both laboratories (Blantyre
and Lilongwe) are fully functional, equipped with embed-
ding processors, microtomes, and automatic staining
machines. At present, hematoxylin and eosin (H&E), peri-
odic acid-Schiff, and Ziehl–Neelsen (ZN) stains are avail-
able. Both labs plan to implement further special
histochemical and basic immunohistochemical stains. There
are expert technicians on both sites, and additional staff is
going to be trained during the next years.
Pathology volunteers
The work of volunteering pathologist mainly consists of
providing diagnostic service, which results in immediate
support for the local pathologists. Furthermore, there is a
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possibility to assist in teaching of the forthcoming pathology
residents (e.g., grossing and histology, preparing teaching
slides), technicians, and clinicians (e.g., performing fine
needle aspirations). The volunteers are self-funded but hous-
ing is provided by Danny Milner and the UNC.
Time period reported
The reported cases encompass our diagnostic workload (SB
and RL) during a 6-week period between November and
December 2011 while working as volunteering pathologists
in Malawi—4 weeks in Blantyre and 2 weeks in Lilongwe.
Results
A total of 405 cases were processed and reviewed, encom-
passing 378 histology specimens (139 biopsies, 133 exci-
sions and curettages, and 106 resection specimens) and 27
cytology cases. The Blantyre load included 326 cases, while
79 cases were seen in Lilongwe. The majority of cases (n0
120, 29.6 %) were from gynecological sites (uterus, ovary,
and breast), followed by gastrointestinal cases (n073; 18 %;
esophagus and colon). An overview about the distribution of
the various sites is given in Fig. 1. Most cases showed
significant pathological findings. In some of the 26 cases
lacking pathological changes, the clinical diagnosis of a
tumor (e.g., stenosing esophageal cancer) implied insuffi-
cient sampling. The cases with pathological findings con-
sisted of 175 (47.4 %) non-tumoral conditions, 39 (10.6 %)
benign tumors or tumor-like lesions, 15 (4.1 %) premalig-
nant changes, and 140 (37.9 %) malignant tumors. Ten cases
(six of them cytology) were technically unsatisfactory.
Macroscopic and histologic pictures of some examples of
the cases are given in Fig. 2. A complete list of all cases is
provided as Electronic supplemental material.
Benign conditions
Eighty-nine cases (22.0 %) showed only degenerative or
functional changes, like disorders of pregnancy (ectopic
pregnancies or missed abortions), Hirschsprung's disease
(n04), cysts, hyperplastic conditions, or fibrosis. Inflamma-
tory conditions as main diagnosis were found in 94 cases
(25.5 %); the most frequent sites being soft tissue, cervix,
uteri, and appendix. Unspecific inflammation was acute (n0
32) or chronic or chronic granulating (n039). Twenty-three
inflammatory cases showed specific histomorphological
findings. Schistosomiasis (n010) was an additional finding
in four malignant cases. There were two cases of a cysticer-
cosis. Eleven cases were consistent with tuberculosis. How-
ever, only one of them could be confirmed by demonstration
of acid-fast bacilli in a ZN staining, resulting in the need for
correlation with microbiological cultures.
Benign tumors and tumor-like lesions
Among the benign tumors, there were 15 epithelial neo-
plasms, e.g., benign salivary gland tumors like pleomorphic
adenomas and ovarian tumors like granulosa cell tumors.
Within the group of benign mesenchymal tumors or tumor-
like lesions, there were leiomyomas of the uterus, heman-
giomas, and spindle cell proliferations of unknown lineage,
which could not be finally classified due to lack of
immunohistochemistry.
Premalignant lesions
The vast majority of premalignant lesions consisted of
cervical intraepithelial neoplasia (CIN I–III), diagnosed in
cervical biopsies, excisions, and three hysterectomy speci-
mens. Two cases showed squamous cell dysplasia of the
conjunctiva.
Malignant tumors
Among the malignant cases were 11 pediatric tumors
(patients under 18 years): three cases of small blue round
cell tumors (not otherwise classifiable), two retinoblastomas,
two cases consistent with rhabdomyosarcoma, and two Kapo-
si's sarcomas. The large group of adult malignant tumors
consisted of 76 cases (58.9 %) from female patients and 53
cases (41.1 %) from male patients. The most frequent malig-
nancies among women were cervical squamous cell carcino-
mas (SCCs; n=25; 32.9% of all female malignancies),
followed by breast carcinomas (n012; 15.8 %), esophagealFig. 1 Topographical distribution of cases
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SCC (n09; 11.8 %), and ovarian carcinomas (n07; 9.2 %).
Within the group of males, the most frequent malignant
tumors were esophageal SCC (n09; 17.0 %) and SCC of the
urinary bladder (n07; 13.2 %). The median age of adult
cancer patients was 43.5 years for females (range, 18–
87 years) and 52 years for males (range, 24–82 years). Of
note, the overall percentage of Kaposi's sarcomas and lym-
phomas was relatively low, with only six cases (4.3 %) and
seven cases (5 %), respectively. Other tumors, like laryngeal
carcinoma, skin cancer, or intestinal cancers were comparably
rare. Metastatic disease was found in ten cases (7.1 %), com-
prising two metastases of primary gastric cancer and eight
metastases without known primary. An overview of the most
frequently seen adult malignancies is given in Tables 1 and 2.
Among the rare or unexpected tumors were (a) a high-
grade sarcoma with rhabdoid features from a 23-year-old
female, presenting as a large abdominal mass, (b) a soft
tissue manifestation (clinical information) of a chondrosar-
coma with extension into the musculus iliopsoas from a 22-
year-old woman, (c) a dysgerminoma of the ovary of an 18-
Fig. 2 Examples of cases. a–c
Very large dermatofibrosarcoma
protuberance of the abdominal
wall (15-year-old male). a
Macroscopic top view. b
Macroscopic cut surface. c
Histology (H&E; ×2.5). d–f
Giant dermal nevus with
underlying large diffuse
neurofibroma (1-year-old girl). d
Overview (H&E; ×2.5)—note
chondroid metaplasia (right
angle). e Dermal nevus (H&E,
×10). fWagner–Meissner bodies
within diffuse neurofibroma
(H&E, ×10). g Collision of a
mature teratoma and a
dysgerminoma in the ovary (18-
year-old female; H&E, ×2.5;
inset, magnification of
dysgerminoma). h Kaposi's
sarcoma of the tonsil region (39-
year-old female; H&E, ×10). i
Colon specimen with
granulomatous inflammation in
the submucosa due to
schistosomiasis (13-year-old
girl, with the clinical diagnosis of
Hirschsprung's disease;
H&E, ×20). j Squamous cell
carcinoma of the urinary bladder
(39-year-old male; H&E, ×20)
with schistosoma eggs (inset,
magnification)
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year-old female with a simultaneous mature teratoma, (d) a
gigantic dermatofibrosarcoma protuberance from a 15-year-
old boy (without fibrosarcomatous areas), and (e) three
cases of malignant melanoma. A number of tumors could
not be finally classified due to the inability to determine the
tumor's lineage due to the lack of additional immuno-
histochemical stains or molecular diagnostics (e.g., for the
determination of specific translocations).
Discussion
In low-resource medicine, it is not uncommon for patholo-
gists to be only rarely involved in the diagnostic process
during the treatment of patients—in benign or malignant
conditions alike. Patients are treated either without a patho-
logic or laboratory diagnosis based on clinical suspicion
alone or are not treated at all. Pathology service in develop-
ing countries is complicated by insufficient infrastructural
conditions and the lack of specialized personnel and techni-
cal equipment [1–3]. Thus, tissue may be submitted for
histopathological examinations just in case of clinically
highly relevant questions. And even in these cases, clinicians
may be faced with long turnover times—often exceeding
many months—and the provision of differential diagnoses
only, especially in those instances when special additional
methods would be mandatory to solve the case.
During the 6 weeks, we had the opportunity to gain
insight into the diagnostic spectrum of a typical histopatho-
logical laboratory in sub-Saharan Africa. A comparison with
statistics of a previous year showed that the variety of our
cases is representative of the average distribution and char-
acter of the annual workload. The majority of biopsies and
excisions received consisted of quantitatively adequate,
well-preserved tissue, enabling high-quality histomorphol-
ogy. Fixation of larger resection specimens was sometimes
unsatisfactory; however, this did not impede diagnosis. In
contrast, fine needle aspiration (FNA), which represents a
much simpler technique requiring far fewer resources, failed
to provide satisfactory diagnostic material in many cases of
our series. This coincides with similar observations from
other low-resource countries and highlights the necessity for
FNA training facilities.
Probably due to the low rate of submitted specimens
mentioned above, the number of cases with significant path-
ologic findings was remarkably high as compared to a
western world pathology laboratory—in particular the per-
centage of malignancies (34.5 vs. 19.2 % in the Institute of
Pathology, Technische Universität München, Germany, dur-
ing the same time period). It is important to keep in mind
that therefore our case series cannot be used to estimate
prevalence. Milner et al. are currently preparing a 10-year
retrospective paper which covers a full pathoepidemiologi-
cal assessment of Malawi's pathology from 1997 to 2007.
Communicable diseases, e.g., malaria, HIV, and tubercu-
losis (including HIV-associated), represent a major cause of
morbidity and mortality in central and southeast Africa [5, 6,
8–10]. In accordance, a significant number of cases were
histomorphologically most consistent with tuberculosis or
atypical mycobacterial infection. This was seen in about half
of the lymph nodes sent in for examination, but also at
various other sites like soft tissue or joints. Using ZN stain-
ing, the presence of acid-fast bacilli could be confirmed in
only one of those cases. However, the ZN results are most
probably false negative due to suboptimal staining proce-
dures, as reported by others in similar settings [11].
Another very interesting finding was the frequency of
schistosomiasis, which is widespread in Malawi like in other
African countries [12, 13]. In our cases, schistosoma eggs
causing inflammation were found at various sites, e.g., the
cervix uteri, the urinary bladder (some as additional finding
to carcinoma), or in the appendix, causing an acute perfo-
rating appendicitis. Of note, schistosomiasis was the definite
histopathological diagnosis in a colon segment of a 13-year-
old girl, which was removed with the clinical diagnosis of
Hirschsprung's disease, and in a hysterectomy specimen
resected due to the clinical impression of a cervical carci-
noma. The majority of inflammatory lesions, although
Table 1 Most frequently seen adult female malignancies
Site No. Percentage Median age
(min–max)
Cervix uteri 23 31.9 42 (28–70)
Breast 11 15.3 50 (29–60)
Esophagus 9 12.5 40 (32–57)
Skin 5 6.9 46 (32–70)
Ovaries 5 6.9 28 (18–52)
Lymphomas 3 4.2 30 (27–50)
Total adult female malignancies 72 100 43 (18–87)
Table 2 Most frequently seen adult male malignancies
Site No. Percentage Median age
(min–max)
Esophagus 9 18 55 (27–79)
Bladder 7 14 39 (28–82)
Soft tissue 5 10 54 (30–76)
Lymphomas 4 8 36 (24–60)
Larynx 4 8 50 (26–76)
Skin 3 6 40 (25–61)
Prostate 3 6 72 (60–76)
Total adult male malignancies 50 100 52 (24–82)
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representing 25 % of the caseload, however, failed to pres-
ent specific etiologic findings.
In the large group of tumoral conditions, the number of
malignant and premalignant cases dominated over benign
conditions. Most benign tumors were soft tissue tumors, e.g.,
leiomyomas of the uterus. There were some rare findings, like
a lipofibromatosis/fibrous hamartoma of infancy or a large
diffuse neurofibroma underlying a giant dermal nevus, as well
as two peripheral ossifying fibromas in the oral cavity.
Although in a number of cases a definitive diagnosis
could not be performed due to lack of ancillary techniques,
we could at least estimate the dignity in all these cases or
provide the most probable differential diagnoses according
to the histomorphological picture. Apart from the soft tissue
tumors, we also saw a considerable number of benign sali-
vary gland tumors, mainly pleomorphic adenomas (n06).
This is consistent with the observation of the high incidence
of salivary gland tumors among African people [14].
Most of the pediatric cases were malignant. Among them
are two retinoblastomas and two rhabdomyosarcomas—one
of them representing a recurrent case with current “small
round cell tumor” morphology. Of note, there were three
other cases of small round cell tumors; one of them probably
a hematolyphoid malignancy. Unfortunately, the lack of
ancillary techniques impeded a definitive diagnosis.
Within the adult malignant cases, the high frequency of
SCC of the cervix uteri and intraepithelial precursor lesions
reflects the incidence of HPV-induced cervical cancer as the
leading malignancy of women in Malawi and most other
African countries [15–17]. Cervical cancer has been shown
to have a strong association with HIV as a co-driving factor
[18]. Unfortunately, the HIV status was only very incon-
stantly provided in the clinical submission forms, rendering
a reliable analysis in this regard fairly impossible. Schisto-
somiasis of the cervix uteri was relatively common (n03),
and one case showed concomitant SCC. An etiologic corre-
lation has not yet been sufficiently investigated.
A striking finding was the high percentage of malignant
squamous lesions at various other sites, like the esophagus,
the urinary bladder, or the conjunctiva. Esophageal squa-
mous cell carcinomas were observed in both females and
males, in a relatively high frequency and with a low median
patient age (45 years). This represents a marked difference
as compared to western countries [16]. Several previous
studies have highlighted the differing carcinogenesis of
esophageal cancer in high-incidence areas like Southeast
Asia or Southern Africa [16, 19, 20]. A number of nutri-
tional or environmental factors have been identified—vary-
ing dependent on the geographic area investigated [21, 22].
HPVand/or HIValso may have major impact on esophageal
carcinogenesis in these countries [23]. However, larger stud-
ies with comprehensive epidemiologic and molecular genet-
ic investigations are still missing in this field.
Conjunctival squamous cell carcinoma is also known to
occur with increased frequency in Africa. This is likely
related to sun exposure and possibly aggravated by viral
infections as HIV; however, the exact etiology of this tumor
remains unknown [24].
SCC of the bladder is known to be strongly associated
with infections by Schistosoma haematobium [12, 16]. In
fact, the presence of parasite eggs was directly demonstrated
in one case of SCC of the bladder and in one case with
epithelial changes indefinite for dysplasia. Among the other
cases, identification of schistosoma eggs was impeded by
extensive tissue infiltration by the SCC.
The incidence of breast cancer in Africa is reported to be
increasing, although it still remains less frequent than in
western countries. In our collection of cases, mammary
carcinomas accounted for 15 % of all female malignancies.
Breast cancer in Africa has been shown to be unusually
aggressive and to affect women at a relatively young age
[16, 25–28]. In our collection, however, only two carcino-
mas were grade III tumors using the Elston and Ellis grading
system, and all were specified as invasive ductal (NOS)—
some of them with an intraductal component. Regarding the
age distribution, five women were 40 years and younger,
which could be expected in accordance with the data men-
tioned above. Interestingly, we saw one case of a male breast
cancer, which was already described to occur relatively
frequently in this part of Africa [29]. Finally, consistent with
the low incidence of lung, colorectal, gastric, and prostatic
cancers in sub-Saharan Africa [16], we only had three
intestinal carcinomas (one of them a carcinoma of the small
intestine), three gastric carcinomas or metastases of gastric
carcinomas, four prostate carcinomas, and no lung
malignancy.
An interesting finding was our low percentage of Kapo-
si's sarcomas, which are described to occur in a frequency of
around 20 % in female and 50 % in male cancer patients in
east Africa [16, 17]. Similarly, albeit in lower extent, the
frequency of lymphomas among our cases did not reach the
expected numbers. This probably represents either sampling
bias during our short visit, clinical acumen at making the
diagnosis without biopsy, and/or the fact that fewer than
20 % of malignancy diagnoses are being confirmed by
laboratory methods (histology, cytology, or hematology)
[30].
Unequivocal clinical findings of malignant tumors, like
Kaposi's sarcoma in HIV patients or Burkitt's lymphoma in
the clinical setting of a rapidly growing mass in association
with a dramatic clinical worsening, do not necessarily war-
rant histopathologic confirmation in the setting of low-
resource medicine. The usual therapy of Kaposi's sarcoma
consists of antiviral treatment plus a trial and error applica-
tion of chemotherapy, if available, and diagnosis is con-
firmed by response [31]. For Burkitt's lymphoma, a rapid
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histopathologic diagnosis would be required, which could
be provided only in a very small number of cases [32, 33].
Therefore, treatment is initiated on clinical diagnosis alone.
One has to consider that this is also true in many other
cases: even a diagnosis of malignancy would not change
therapy due to the lack of adequate therapeutic options.
However, in many low-resource countries, medical service
improves slowly but steadily as countries progress to higher
economic status [34]. Surgical and nonsurgical treatment of
oncologic diseases is performed (we saw a case of a breast
cancer with the previous history of neoadjuvant chemother-
apy). Therefore, adequate pathology services can lead to the
recognition of pathology as an integral part of a multidisci-
plinary healthcare setting. An example is the consensus
guideline on breast health care in low-resource and
middle-resource countries of the Breast Health Global Ini-
tiative, which requires a pathologic diagnosis before the
initiation of treatment [35]. Providing pathology service in
low-resource countries therefore not only challenges pathol-
ogists with difficult working conditions and extraordinary
and rare cases, but also provides patient access to better,
tailored, and potentially even curative therapies.
There are several modes of support for pathology serv-
ices: One may be support of already existing laboratories,
like the pathologists for Malawi project does, providing
immediate load relief for local physicians or covering them
during professional education periods. Laboratories, which
have been closed due to breakdown of technical equipment
and lack of pathologists, can be reestablished [36], and
exchange programs can help in forming local pathologists
[1]. Teaching clinicians about what can be expected from a
pathologic diagnosis can be very helpful, as well as training
in performing biopsies and FNAs—the most useful tech-
nique in low-resource settings. The immediate feedback
given by the pathologists about the quality of the tissue or
smears is most often a first, but very important, step for
improving quality [37].
Apart from activities by individuals, there are a few
organizations, which are coordinating support for pathology
in low-resource countries: “Pathologists overseas” (contact:
hoenecke57@gmail.com) has been active for almost
20 years [38]. “Pathologists and technicians in favor of
developing countries” is a working group within the Euro-
pean Society of Pathology, which mainly consists of mem-
bers of the Italian organization “Patologi Oltre Frontiera”
(www.patologioltrefrontiera.it). They have already per-
formed and are currently conducting several projects in
African and Asian countries, e.g., the implementation of
telepathology in combination with training of local physi-
cians [11].
In summary, our volunteering work gave us a broad
insight into the spectrum of diseases that pathologists can
expect in sub-Saharan countries [39, 40] and the challenges
that pathology is faced with in low-resource settings. While
working as volunteering pathologists, both a rich cultural
and an intellectually stimulating professional experience can
be achieved, at the same time providing a much needed and
appreciated diagnostic service.
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